+
Site Tour

Search

Showing 71 - 80 of 523 results.

  • Diagnosis

    Most early-stage TR is clinically silent,1 and even with severe TR, some patients may be asymptomatic.27 In patients who become symptomatic of TR, the prevalence and severity of the symptoms are grea

  • Diagnosis

    The three cardinal symptoms of AS are angina, syncope or heart failure (HF).13,16 Other symptoms include dyspnea and decreased exercise tolerance.14 Primary care physicians should consider AS in ad

  • Clinical Data

    AMPLATZER™ MUSCULAR VSD OCCLUDER DEMONSTRATED CLOSURE SUCCESS IN PATIENTS WITH VSD The Amplatzer™ Muscular VSD Occluder was evaluated in a prospective, non-randomized, multi-center clinical study

  • Clinical Data

    STUDY DATA DESIGN N HF HOSPITALIZATION PA PRESSURE HFpEF SAFETY QOL ADHERENCE NYHA CLASSIII ELEVATED BNP1,* NYHA CLASS II1,*

  • Options

    As recommended in the 2020 American College of Cardiology/American Heart Association (ACC/AHA) and 2021 ESC/EACTS guidelines,38,39 patients with TR should be managed by a multidisciplinary heart tea

  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  LEARN MORE: Data summary  PFO Neurology Brochure THE LANDMARK RESPECT TRIAL2S

  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure INTERVENTIONAL DEVICE EXEMPTION AND PICCOLO CLINICAL TRIAL RESULTS CLINICAL CASE REPOR

  • Recommendations

    LEARN MORE: Clinical Trial Summary  EARLY DEVICE INTERVENTION  MODIFIED PDA CLOSURE Early PDA closure can lead to rapid improvement in respiratory status and faster weaning off ventilat

  • EPIC™ Max Clinical Data

    AT 10 YEARS LEARN MORE: EPIC MAX BROCHURE COMMITED TO VALVE-IN-VALVE* FOLLOW-UP DATA 3-YEAR OUTCOMES OF VALVE-IN-VALVE INTERVENTION IN A U.S. POPULATION Maximizing the internal orifice prov

  • Features

    Silicone-Filled Cuff FlexFitTM Polymer Stent Unique Pericar

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline